Pharmaceutical

Lundbeck acquires all outstanding shares of Longboard P...

Lundbeck has completed the acquisition of all outstanding shares of Longboard Ph...

FDA approves AstraZeneca’s Imfinzi to treat LS-SCLC

The US FDA has approved AstraZeneca's Imfinzi (durvalumab), to treat limited-sta...

CEO of UnitedHealthcare, Brian Thompson, shot dead in N...

US police have confirmed that Brian Thompson was fatally shot outside an investo...

Lilly’s Zepbound wins the weight loss duel with Novo’s ...

An open-label Phase III trial showed that participants using Zepbound saw 47% gr...

Maze Therapeutics raises $115m to advance kidney diseas...

Maze Therapeutics has completed a Series D financing round, raising $115m to pro...

Ipsen and Biomunex enter agreement for cancer therapy

Ipsen has entered an exclusive worldwide licensing agreement with Biomunex Pharm...

Takeda licensed for anaemia therapy by Keros Therapeutics

Takeda has signed an agreement to receive an exclusive global licence from Keros...

All-in-one milling platforms: How to reduce your machin...

Many machines are required for pharmaceutical milling processes. Can you reduce ...

Trump 2.0 could see a rise in biopharmaceutical M&A deals

A change in FTC leadership would likely see a relaxation of antitrust enforcemen...

From Cobenfy to Emraclidine: the muscarinic path to saf...

Drugs such as Cobenfy could reshape the antipsychotic market, providing a more n...

CBC acquires UCB’s neurology and allergy business in China

CBC Group has completed the strategic acquisition of UCB's mature neurology and ...

UQ secures funds for development of skin cancer prevent...

The research team at UQ has secured a grant of $344,000 from the National Founda...

PrEP therapies offer new hope in HIV preventive landsca...

The HIV vaccine space has seen dwindling research activity as drug manufacturers...

J&J’s sBLAs seek FDA approval of TREMFYA for paediatric...

J&J is seeking approval of TREMFYA for paediatric conditions with the submission...

Novartis and PTC Therapeutics link to develop Huntingto...

Novartis has entered a worldwide licence and partnership agreement with PTC Ther...

Faron Pharma secures UK innovation passport for blood c...

The MHRA has also granted approval to Faron Pharmaceuticals to conduct the BEXMA...